Digital Media Net - Your Gateway To Digital media Creation. News and information on Digital Video, VR, Animation, Visual Effects, Mac Based media. Post Production, CAD, Sound and Music
Categories: News

Glancy Prongay & Murray LLP Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Meta Platforms, Inc. (FB)

Shareholders with $100,000 losses or more are encouraged to contact the firm.

LOS ANGELES–(BUSINESS WIRE)–Glancy Prongay & Murray LLP (“GPM”) reminds investors of the upcoming May 9, 2022 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased or otherwise acquired Meta Platforms, Inc. (“Meta” or the “Company”) (NASDAQ: FB) securities between March 2, 2021 and February 2, 2022, inclusive (the “Class Period”).

If you suffered a loss on your Meta investments or would like to inquire about potentially pursuing claims to recover your loss under the federal securities laws, you can submit your contact information at www.glancylaw.com/cases/meta-platforms-inc/. You can also contact Charles H. Linehan, of GPM at 310-201-9150, Toll-Free at 888-773-9224, or via email at shareholders@glancylaw.com to learn more about your rights.

On July 28, 2021, Meta held a conference call to discuss its second quarter 2021 financial results, during which Chief Financial Officer, David Wehner, stated that the Company “continue[s] to expect increased ad targeting headwinds in 2021 from regulatory and platform changes, notably the recent iOS updates, which we expect to have a more significant impact in the third quarter compared to the second quarter.”

On this news, the Company’s stock price fell $14.96 to close at $358.32 per share on July 29, 2021.

Then, on October 25, 2021, Meta held a conference call to discuss its third quarter 2021 financial results, during which management stated that the iOS changes led to two challenges: “One is that the accuracy of our ads targeting decreased, which decreased the cost of driving outcomes for our advertisers. And the other is that measuring those outcomes became more difficult.”

On this news, the Company’s stock price fell $12.88 to close at $315.81 per share on October 26, 2021.

Then, on February 2, 2022, after the market closed, Meta announced disappointing fourth quarter 2021 financial results, including earnings per share of $3.67, below estimates of $3.84 earnings per share. The Company also expected first quarter 2022 revenue between $27 billion and $29 billion, below analysts’ expectations of $30.25 billion. During a related earnings call, the Company disclosed that Apple’s iOS privacy changes had negatively impacted Meta’s advertising business.

On this news, the Company’s stock price fell $85.24, or 26.4%, to close at $237.76 per share on February 3, 2022, thereby injuring investors.

The complaint alleges that defendants throughout the Class Period made false and/or misleading statements and/or failed to disclose that: (1) Apple’s iOS privacy changes were having a material impact on Meta’s ability to provide the kind of targeted advertising that its customers wanted and, as a result, customer ad spending was dropping precipitously; (2) Meta’s mitigation efforts were either not properly implemented or ineffective; (3) measurement of ads was not accurate as mitigation efforts were failing; and (4) Meta did not have a plan in place to properly address the impact of the iOS privacy changes; and (5) as a result of the foregoing, Defendants’ public statements were materially false and misleading at all relevant times.

Follow us for updates on LinkedIn, Twitter, or Facebook.

If you purchased or otherwise acquired Meta securities during the Class Period, you may move the Court no later than May 9, 2022 to request appointment as lead plaintiff in this putative class action lawsuit. To be a member of the class action you need not take any action at this time; you may retain counsel of your choice or take no action and remain an absent member of the class action. If you wish to learn more about this class action, or if you have any questions concerning this announcement or your rights or interests with respect to the pending class action lawsuit, please contact Charles Linehan, Esquire, of GPM, 1925 Century Park East, Suite 2100, Los Angeles, California 90067 at 310-201-9150, Toll-Free at 888-773-9224, by email to shareholders@glancylaw.com, or visit our website at www.glancylaw.com. If you inquire by email please include your mailing address, telephone number and number of shares purchased.

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.

Contacts

Glancy Prongay & Murray LLP, Los Angeles

Charles Linehan, 310-201-9150 or 888-773-9224

shareholders@glancylaw.com
www.glancylaw.com

Staff

Recent Posts

Macnica Americas Names Veteran Engineering Executive Nestor Amaya as Vice President of Engineering

SOLANA BEACH, Calif.--(BUSINESS WIRE)--Macnica Americas today announced the appointment of Nestor Amaya as Vice President…

5 hours ago

Filed Late? The IRS May Have Already Filed for You – Clear Start Tax Explains Why Substitute Returns Often Inflate What You Owe

Every year, millions of Americans who miss their tax filing deadlines assume the IRS is…

11 hours ago

Genius Sports and Liga MX Strike Landmark Technology and AI Partnership to Drive Future of Mexican Soccer

Genius Sports has deployed its cutting-edge data and AI platform GeniusIQ in every Liga MX…

11 hours ago

Best Buy Introduces Reward Points for My Best Buy Plus and Total Members

Starting June 4, My Best Buy Plus™ and My Best Buy Total™ members will automatically…

12 hours ago

Ncontracts Introduces Nquiry: AI-Powered Regulatory Intelligence That Delivers Defensible Compliance Answers in Minutes

New platform combines 17 years of proprietary compliance data with direct access to credentialed experts,…

12 hours ago

Prometheus Signals Near-Term Development of Next-Generation Noninvasive Test for MASH Patients at DDW 2026

Translational Data Inform a Scalable, Noninvasive Test Designed to Identify Treatment-Eligible Patients and Enable Longitudinal…

1 day ago